Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDActual EPS
Allarity Therapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
Allarity Therapeutics, Inc. Earnings Date And Information
Allarity Therapeutics, Inc. last posted its earnings results on Thursday, November 14th, 2024. The company reported $-7.71 earnings per share for the quarter, topping analysts' consensus estimates of $-8.52 by $0.81. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Allarity Therapeutics, Inc. has generated $0 earnings per share over the last year ($-0.0103 diluted earnings per share) and currently has a price-to-earnings ratio of -0.07. Allarity Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, March 14th, 2025 based on prior year's report dates.
Allarity Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/14/2024 | Q3 2024 | -$8.52 | -$8.09 | 0.43 | $0 | $0 |
| 08/05/2024 | Q2 2024 | -$0.29 | -$3.40 | -3.11 | $0 | $0 |
| 05/14/2024 | Q1 2024 | -$1.76 | -$696.83 | -695.07 | N/A | $0 |
| 04/29/2024 | Q4 2023 | N/A | -$175.51 | N/A | N/A | $112,000 |
| 11/14/2023 | Q3 2023 | -$8.17 | -$1,346.09 | -1337.92 | N/A | $0 |
| 08/14/2023 | Q2 2023 | -$11.19 | -$15,766.00 | -15754.81 | N/A | $0 |
| 05/11/2023 | Q1 2023 | -$7.88 | -$106,238.00 | -106230.12 | N/A | $0 |
| 03/10/2023 | Q4 2022 | -$0.42 | -$192,763.00 | -192762.58 | N/A | $0 |
| 11/14/2022 | Q3 2022 | N/A | -$568,688.00 | N/A | N/A | $0 |
| 10/07/2022 | Q2 2022 | -$0.25 | -$603,674.00 | -603673.75 | N/A | $0 |
| 05/27/2022 | Q1 2022 | -$528.00 | -$471,466.00 | -470938 | N/A | $0 |
| 05/16/2022 | Q4 2021 | N/A | -$1,744,848.00 | N/A | N/A | $0 |
| 11/23/2021 | Q3 2021 | N/A | -$146,370.00 | N/A | N/A | $0 |
| 06/30/2021 | Q2 2021 | N/A | -$15,716.00 | N/A | N/A | $0 |
| 03/31/2021 | Q1 2021 | N/A | -$205,363.00 | N/A | N/A | $0 |
| 12/31/2020 | Q4 2020 | N/A | $0.00 | N/A | N/A | $0 |
| 09/29/2020 | Q3 2020 | N/A | -$4,326.00 | N/A | N/A | $0 |
| 06/30/2020 | Q2 2020 | N/A | $0.00 | N/A | N/A | $1.07 M |
| 03/31/2020 | Q1 2020 | N/A | $0.00 | N/A | N/A | $0 |
| 12/31/2019 | Q4 2019 | N/A | $0.00 | N/A | N/A | $357,579 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Allarity Therapeutics, Inc. Earnings: FAQ's
Allarity Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, March 14th, 2025 based offlast year's report dates.
In the previous quarter, Allarity Therapeutics, Inc. (:ALLR) reported $-7.71 earnings per share (EPS) to beat the analysts' consensus estimate of $-8.52 by $0.81.
The conference call for Allarity Therapeutics, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Allarity Therapeutics, Inc.'s latest earnings report can be read online.
Allarity Therapeutics, Inc. (:ALLR) has a recorded net income of $-11,901,000.Allarity Therapeutics, Inc. has generated $-0.0103 earnings per share over the last four quarters.
Allarity Therapeutics, Inc. (:ALLR) has a price-to-earnings ratio of -0.07 and price/earnings-to-growth ratio is -0.